{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:25:23Z","timestamp":1784892323512,"version":"3.55.0"},"reference-count":219,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.phrs.2022.106352","type":"journal-article","created":{"date-parts":[[2022,7,11]],"date-time":"2022-07-11T21:56:25Z","timestamp":1657576585000},"page":"106352","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"special_numbering":"C","title":["Saponins and their derivatives: Potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance"],"prefix":"10.1016","volume":"182","author":[{"given":"Pei-Rong","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Lin","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping-Ping","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan-Chun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl 4","key":"10.1016\/j.phrs.2022.106352_bib1","first-page":"3","article-title":"The discovery of daunorubicin","volume":"65","author":"Di Marco","year":"1981","journal-title":"Cancer Treat. Rep."},{"key":"10.1016\/j.phrs.2022.106352_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-pharmtox-030620-104842","article-title":"Preventing and Treating Anthracycline Cardiotoxicity: New Insights","volume":"61","author":"Sawicki","year":"2021","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106352_bib3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jacc.2014.06.1167","article-title":"Prevention of anthracycline-induced cardiotoxicity: challenges and opportunities","volume":"64","author":"Vejpongsa","year":"2014","journal-title":"J. Am. Coll. Cardiol."},{"issue":"23","key":"10.1016\/j.phrs.2022.106352_bib4","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.1111\/bph.12995","article-title":"Protective effect of 23-hydroxybetulinic acid on doxorubicin-induced cardiotoxicity: a correlation with the inhibition of carbonyl reductase-mediated metabolism","volume":"172","author":"Zhou","year":"2015","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib5","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1124\/jpet.111.190264","article-title":"Pharmacokinetic characterization of amrubicin cardiac safety in an ex vivo human myocardial strip model. II. Amrubicin shows metabolic advantages over doxorubicin and epirubicin","volume":"341","author":"Salvatorelli","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2022.106352_bib6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s40959-019-0054-5","article-title":"Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors","volume":"5","author":"Bansal","year":"2019","journal-title":"Cardio Oncol."},{"issue":"22","key":"10.1016\/j.phrs.2022.106352_bib7","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","article-title":"Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy","volume":"131","author":"Cardinale","year":"2015","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27030616","article-title":"Multidrug resistance (MDR): a widespread phenomenon in pharmacological therapies","volume":"27","author":"Catalano","year":"2022","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib9","doi-asserted-by":"crossref","first-page":"7734","DOI":"10.1096\/fj.201802707R","article-title":"Physiological levels of chromogranin A prevent doxorubicin-induced cardiotoxicity without impairing its anticancer activity","volume":"33","author":"Rocca","year":"2019","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib10","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ejhf.1439","article-title":"The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity","volume":"21","author":"Russo","year":"2019","journal-title":"Eur. J. Heart Fail"},{"key":"10.1016\/j.phrs.2022.106352_bib11","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6153772","article-title":"Endogenous hydrogen sulfide persulfidates caspase-3 at cysteine 163 to inhibit doxorubicin-induced cardiomyocyte apoptosis","volume":"2022","author":"Ye","year":"2022","journal-title":"Oxid. Med Cell Longev."},{"issue":"13","key":"10.1016\/j.phrs.2022.106352_bib12","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.ejca.2013.04.030","article-title":"Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: a systematic review and meta-analysis","volume":"49","author":"Kalam","year":"2013","journal-title":"Eur. J. Cancer (Oxf., Engl.: 1990)"},{"issue":"5","key":"10.1016\/j.phrs.2022.106352_bib13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1200\/JCO.2005.02.3879","article-title":"Dexrazoxane-associated risk for acute myeloid leukemia\/myelodysplastic syndrome and other secondary malignancies in pediatric Hodgkin\u2019s disease","volume":"25","author":"Tebbi","year":"2007","journal-title":"J. Clin. Oncol.: Off. J. Am. Soc. Clin. Oncol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib14","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/leu.2009.261","article-title":"Long-term results of the pediatric oncology group studies for childhood acute lymphoblastic leukemia 1984-2001: a report from the children's oncology group","volume":"24","author":"Salzer","year":"2010","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib15","article-title":"Statin induced autoimmune necrotizing myopathy (SIANM): an alarming adverse event of a familiar medication","volume":"14","author":"Ganta","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.phrs.2022.106352_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ejmech.2017.06.047","article-title":"Natural alkaloids as P-gp inhibitors for multidrug resistance reversal in cancer","volume":"138","author":"Joshi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"17","key":"10.1016\/j.phrs.2022.106352_bib17","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1111\/bph.13909","article-title":"A novel individual-cell-based mathematical model based on multicellular tumour spheroids for evaluating doxorubicin-related delivery in avascular regions","volume":"174","author":"Liu","year":"2017","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106352_bib18","article-title":"Chemical synthesis of saponins","volume":"79","author":"Yang","year":"2021","journal-title":"Adv. Carbohydr. Chem. Biochem."},{"issue":"10","key":"10.1016\/j.phrs.2022.106352_bib19","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.phytochem.2010.04.003","article-title":"Dammarane saponins from Gynostemma pentaphyllum","volume":"71","author":"Hu","year":"2010","journal-title":"Phytochemistry"},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib20","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1021\/np0700671","article-title":"Oleanane saponins from Stylosanthes erecta","volume":"70","author":"De Leo","year":"2007","journal-title":"J. Nat. Prod."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","article-title":"Free radicals and antioxidants in normal physiological functions and human disease","volume":"39","author":"Valko","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106352_bib22","doi-asserted-by":"crossref","DOI":"10.3390\/nu9090966","article-title":"Antioxidant therapeutic strategies for cardiovascular conditions associated with oxidative stress","volume":"9","author":"Far\u00edas","year":"2017","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jchromb.2004.05.017","article-title":"Subcellular metabolite profiles of the parent CCRF-CEM and the derived CEM\/C2 cell lines after treatment with doxorubicin","volume":"808","author":"Anderson","year":"2004","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"12","key":"10.1016\/j.phrs.2022.106352_bib24","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/ptr.1783","article-title":"Protective effect of Spirulina against doxorubicin-induced cardiotoxicity","volume":"19","author":"Khan","year":"2005","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.phrs.2022.106352_bib25","article-title":"Saikosaponin D alleviates DOX-induced cardiac injury in vivo and in vitro","author":"Zhang","year":"2021","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib26","first-page":"460","article-title":"Effect of anthracycline antibiotics on oxygen radical formation in rat heart","volume":"43","author":"Doroshow","year":"1983","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0163-7258(90)90088-J","article-title":"Doxorubicin (adriamycin): a critical review of free radical-dependent mechanisms of cytotoxicity","volume":"47","author":"Keizer","year":"1990","journal-title":"Pharmacol. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib28","doi-asserted-by":"crossref","first-page":"3068","DOI":"10.1016\/S0021-9258(17)35747-2","article-title":"Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical","volume":"261","author":"Doroshow","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0009-2797(77)90050-3","article-title":"Adriamycin stimulated superoxide formation in submitochondrial particles","volume":"19","author":"Thayer","year":"1977","journal-title":"Chem. -Biol. Interact."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S1734-1140(09)70018-0","article-title":"Anthracycline-induced cardiotoxicity: overview of studies examining the roles of oxidative stress and free cellular iron","volume":"61","author":"Sim\u016fnek","year":"2009","journal-title":"Pharmacol. Rep.: PR"},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib31","first-page":"771","article-title":"Cumulative and irreversible cardiac mitochondrial dysfunction induced by doxorubicin","volume":"61","author":"Zhou","year":"2001","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib32","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12012-007-0009-1","article-title":"Role of mtDNA lesions in anthracycline cardiotoxicity","volume":"7","author":"Lebrecht","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib33","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri1312","article-title":"NOX enzymes and the biology of reactive oxygen","volume":"4","author":"Lambeth","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.coph.2008.10.001","article-title":"Selective targeting of NADPH oxidase for cardiovascular protection","volume":"9","author":"Cave","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"issue":"21","key":"10.1016\/j.phrs.2022.106352_bib35","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1111\/bph.13773","article-title":"Signalling mechanisms underlying doxorubicin and Nox2 NADPH oxidase-induced cardiomyopathy: involvement of mitofusin-2","volume":"174","author":"McLaughlin","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"15","key":"10.1016\/j.phrs.2022.106352_bib36","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1089\/ars.2020.8019","article-title":"Signaling pathways underlying anthracycline cardiotoxicity","volume":"32","author":"Sala","year":"2020","journal-title":"Antioxid. Redox Signal."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0008-6363(00)00078-X","article-title":"Status of myocardial antioxidants in ischemia-reperfusion injury","volume":"47","author":"Dhalla","year":"2000","journal-title":"Cardiovasc. Res."},{"issue":"10","key":"10.1016\/j.phrs.2022.106352_bib38","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.phymed.2015.06.010","article-title":"Ginsenoside Rg3 antagonizes adriamycin-induced cardiotoxicity by improving endothelial dysfunction from oxidative stress via upregulating the Nrf2-ARE pathway through the activation of akt","volume":"22","author":"Wang","year":"2015","journal-title":"Phytomedicine"},{"issue":"24","key":"10.1016\/j.phrs.2022.106352_bib39","first-page":"2632","article-title":"[Study on protective effects of Panax notoginseng saponins on doxorubicin-induced myocardial damage]","volume":"32","author":"Shi","year":"2007","journal-title":"Zhongguo Zhong Yao Za Zhi Zhongguo Zhongyao Zazhi China J. Chin. Mater. Med."},{"key":"10.1016\/j.phrs.2022.106352_bib40","article-title":"Ocotillol enhanced the antitumor activity of doxorubicin via p53-dependent apoptosis","volume":"2013","author":"Wang","year":"2013","journal-title":"Evid. -Based Complement. Altern. Med. ECAM"},{"key":"10.1016\/j.phrs.2022.106352_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172490","article-title":"Astragaloside IV alleviates doxorubicin induced cardiomyopathy by inhibiting NADPH oxidase derived oxidative stress","volume":"859","author":"Lin","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib42","first-page":"60","article-title":"Protective effect of oleanolic acid on oxidative injury and cellular abnormalities in doxorubicin induced cardiac toxicity in rats","volume":"8","author":"Goyal","year":"2016","journal-title":"Am. J. Transl. Res."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib43","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/FJC.0000000000001206","article-title":"Saikosaponin D alleviates DOX-induced cardiac injury in vivo and in vitro","volume":"79","author":"Zhang","year":"2022","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib44","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/jpet.114.219261","article-title":"Ophiopogonin D attenuates doxorubicin-induced autophagic cell death by relieving mitochondrial damage in vitro and in vivo","volume":"352","author":"Zhang","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00005-009-0051-8","article-title":"Cardiomyocyte death in doxorubicin-induced cardiotoxicity","volume":"57","author":"Zhang","year":"2009","journal-title":"Arch. Immunol. Et. Ther. Exp."},{"issue":"5","key":"10.1016\/j.phrs.2022.106352_bib46","first-page":"842","article-title":"Annexin V imaging of acute doxorubicin cardiotoxicity (apoptosis) in rats, Journal of nuclear medicine: official publication","volume":"45","author":"Bennink","year":"2004","journal-title":"Soc. Nucl. Med."},{"issue":"13","key":"10.1016\/j.phrs.2022.106352_bib47","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1161\/01.CIR.0000160359.49478.C2","article-title":"Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity","volume":"111","author":"Fisher","year":"2005","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0022-3565(24)29403-9","article-title":"Metallothionein inhibits doxorubicin-induced mitochondrial cytochrome c release and caspase-3 activation in cardiomyocytes","volume":"298","author":"Wang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0092-8674(04)00046-7","article-title":"Cell death: critical control points","volume":"116","author":"Danial","year":"2004","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib50","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell death Dis."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12012-007-0008-2","article-title":"Adriamycin-induced interference with cardiac mitochondrial calcium homeostasis","volume":"7","author":"Wallace","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2174\/157339611796892265","article-title":"Apoptosis in anthracycline cardiomyopathy","volume":"7","author":"Shi","year":"2011","journal-title":"Curr. Pediatr. Rev."},{"issue":"12","key":"10.1016\/j.phrs.2022.106352_bib53","first-page":"3730","article-title":"The CO\/HO system reverses inhibition of mitochondrial biogenesis and prevents murine doxorubicin cardiomyopathy","volume":"117","author":"Suliman","year":"2007","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib54","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1248\/cpb.c13-00556","article-title":"Astragaloside IV inhibits doxorubicin-induced cardiomyocyte apoptosis mediated by mitochondrial apoptotic pathway via activating the PI3K\/Akt pathway","volume":"62","author":"Jia","year":"2014","journal-title":"Chem. Pharm. Bull."},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib55","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1083\/jcb.201110131","article-title":"The impact of the unfolded protein response on human disease","volume":"197","author":"Wang","year":"2012","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.phrs.2022.106352_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104516","article-title":"The role of MicroRNAs on endoplasmic reticulum stress in myocardial ischemia and cardiac hypertrophy","volume":"150","author":"Omidkhoda","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/nrm3270","article-title":"The unfolded protein response: controlling cell fate decisions under ER stress and beyond","volume":"13","author":"Hetz","year":"2012","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib58","first-page":"3722","article-title":"Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy","volume":"46","author":"Torti","year":"1986","journal-title":"Cancer Res."},{"issue":"6059","key":"10.1016\/j.phrs.2022.106352_bib59","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1126\/science.1209038","article-title":"The unfolded protein response: from stress pathway to homeostatic regulation","volume":"334","author":"Walter","year":"2011","journal-title":"Sci. (N. Y., N. Y. )"},{"issue":"9","key":"10.1016\/j.phrs.2022.106352_bib60","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/sj.embor.7400779","article-title":"Mediators of endoplasmic reticulum stress-induced apoptosis","volume":"7","author":"Szegezdi","year":"2006","journal-title":"EMBO Rep."},{"key":"10.1016\/j.phrs.2022.106352_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105383","article-title":"Endoplasmic reticulum stress in doxorubicin-induced cardiotoxicity may be therapeutically targeted by natural and chemical compounds: a review","volume":"164","author":"Yarmohammadi","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"11","key":"10.1016\/j.phrs.2022.106352_bib62","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113658","article-title":"Ginsenoside Rg1 prevents doxorubicin-induced cardiotoxicity through the inhibition of autophagy and endoplasmic reticulum stress in mice","volume":"19","author":"Xu","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib63","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12012-007-0023-3","article-title":"Dexrazoxane: how it works in cardiac and tumor cells. Is it a prodrug or is it a drug?","volume":"7","author":"Hasinoff","year":"2007","journal-title":"Cardiovasc. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib64","doi-asserted-by":"crossref","DOI":"10.1161\/01.RES.86.1.8","article-title":"Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription","volume":"86","author":"Arai","year":"2000","journal-title":"Circ. Res."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215992","article-title":"CaMKII activation participates in doxorubicin cardiotoxicity and is attenuated by moderate GRP78 overexpression","volume":"14","author":"Tscheschner","year":"2019","journal-title":"PloS One"},{"issue":"5","key":"10.1016\/j.phrs.2022.106352_bib66","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.yjmcc.2011.07.016","article-title":"CaMKII-dependent SR Ca leak contributes to doxorubicin-induced impaired Ca handling in isolated cardiac myocytes","volume":"51","author":"Sag","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib67","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/cvr\/cvz240","article-title":"Impaired NF-\u03baB signalling underlies cyclophilin D-mediated mitochondrial permeability transition pore opening in doxorubicin cardiomyopathy","volume":"116","author":"Dhingra","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.phrs.2022.106352_bib68","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.CIR.102.5.572","article-title":"Fas-mediated apoptosis in adriamycin-induced cardiomyopathy in rats: In vivo study","volume":"102","author":"Nakamura","year":"2000","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib69","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0008-6363(02)00646-6","article-title":"Reactive oxygen species regulate FLICE inhibitory protein (FLIP) and susceptibility to Fas-mediated apoptosis in cardiac myocytes","volume":"57","author":"Nitobe","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib70","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1124\/jpet.108.146423","article-title":"Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice","volume":"328","author":"Niu","year":"2009","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Pt 2","key":"10.1016\/j.phrs.2022.106352_bib71","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1042\/BJ20050285","article-title":"Doxorubicin activates nuclear factor of activated T-lymphocytes and Fas ligand transcription: role of mitochondrial reactive oxygen species and calcium","volume":"389","author":"Kalivendi","year":"2005","journal-title":"Biochem. J."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib72","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/cdd.2011.155","article-title":"Regulation of CD95\/Fas signaling at the DISC","volume":"19","author":"Lavrik","year":"2012","journal-title":"Cell Death Differ."},{"issue":"Pt 3","key":"10.1016\/j.phrs.2022.106352_bib73","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1042\/bj20020752","article-title":"Activation of nuclear factor-kappaB during doxorubicin-induced apoptosis in endothelial cells and myocytes is pro-apoptotic: the role of hydrogen peroxide","volume":"367","author":"Wang","year":"2002","journal-title":"Biochem. J."},{"issue":"18","key":"10.1016\/j.phrs.2022.106352_bib74","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1161\/01.CIR.0000146889.46519.27","article-title":"Modulation of doxorubicin-induced cardiac dysfunction in toll-like receptor-2-knockout mice","volume":"110","author":"Nozaki","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib75","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/sj.bjc.6603640","article-title":"Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice","volume":"96","author":"Bruynzeel","year":"2007","journal-title":"Br. J. Cancer"},{"issue":"11","key":"10.1016\/j.phrs.2022.106352_bib76","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1161\/01.CIR.0000121354.34067.48","article-title":"Cyclooxygenase-2 inhibitor treatment improves left ventricular function and mortality in a murine model of doxorubicin-induced heart failure","volume":"109","author":"Delgado","year":"2004","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.phrs.2022.106352_bib77","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1158\/0008-5472.CAN-15-3034","article-title":"Doxorubicin-induced systemic inflammation is driven by upregulation of toll-like receptor TLR4 and endotoxin leakage","volume":"76","author":"Wang","year":"2016","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib78","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.cardiores.2006.09.011","article-title":"Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response","volume":"72","author":"Boyd","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2022.106352_bib79","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1600-065X.2007.00579.x","article-title":"The grateful dead: damage-associated molecular pattern molecules and reduction\/oxidation regulate immunity","volume":"220","author":"Lotze","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.phrs.2022.106352_bib80","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/9874109","article-title":"The role of toll-like receptor signaling in the progression of heart failure","volume":"2018","author":"Yu","year":"2018","journal-title":"Mediat. Inflamm."},{"issue":"12","key":"10.1016\/j.phrs.2022.106352_bib81","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.4161\/cbt.11.12.15540","article-title":"Doxorubicin and daunorubicin induce processing and release of interleukin-1\u03b2 through activation of the NLRP3 inflammasome","volume":"11","author":"Sauter","year":"2011","journal-title":"Cancer Biol. Ther."},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib82","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0040763","article-title":"Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice","volume":"7","author":"Ma","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib83","doi-asserted-by":"crossref","first-page":"H460","DOI":"10.1152\/ajpheart.00056.2019","article-title":"Embryonic stem cell-derived exosomes inhibit doxorubicin-induced TLR4-NLRP3-mediated cell death-pyroptosis","volume":"317","author":"Tavakoli Dargani","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"10","key":"10.1016\/j.phrs.2022.106352_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101224","article-title":"Exosome treatment enhances anti-inflammatory M2 macrophages and reduces inflammation-induced pyroptosis in doxorubicin-induced cardiomyopathy","volume":"8","author":"Singla","year":"2019","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib85","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Pyroptosis: gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochem. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2022.106352_bib86","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.it.2019.09.005","article-title":"Emerging activators and regulators of inflammasomes and pyroptosis","volume":"40","author":"Xue","year":"2019","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2022.106352_bib87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.yjmcc.2019.08.009","article-title":"Doxorubicin induces cardiomyocyte pyroptosis via the TINCR-mediated posttranscriptional stabilization of NLR family pyrin domain containing 3","volume":"136","author":"Meng","year":"2019","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2022.106352_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.117186","article-title":"Bnip3 mediates doxorubicin-induced cardiomyocyte pyroptosis via caspase-3\/GSDME","volume":"242","author":"Zheng","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2022.106352_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112133","article-title":"MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis","volume":"143","author":"Zhang","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib90","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1111\/jcmm.14130","article-title":"Ursolic acid prevents doxorubicin-induced cardiac toxicity in mice through eNOS activation and inhibition of eNOS uncoupling","volume":"23","author":"Mu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.phrs.2022.106352_bib91","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/CMAR.S186696","article-title":"Pristimerin protects against doxorubicin-induced cardiotoxicity and fibrosis through modulation of Nrf2 and MAPK\/NF-kB signaling pathways","volume":"11","author":"El-Agamy","year":"2019","journal-title":"Cancer Manag. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib92","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/13880209.2019.1577467","article-title":"Effects of steroidal saponins extract from Ophiopogon japonicus root ameliorates doxorubicin-induced chronic heart failure by inhibiting oxidative stress and inflammatory response","volume":"57","author":"Wu","year":"2019","journal-title":"Pharm. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib93","doi-asserted-by":"crossref","first-page":"4938","DOI":"10.3390\/nu7064938","article-title":"In vivo protective effects of diosgenin against doxorubicin-induced cardiotoxicity","volume":"7","author":"Chen","year":"2015","journal-title":"Nutrients"},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib94","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1056\/NEJMra1205406","article-title":"Autophagy in human health and disease","volume":"368","author":"Choi","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib95","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800008","article-title":"Three distinct types of microautophagy based on membrane dynamics and molecular machineries","volume":"40","author":"Oku","year":"2018","journal-title":"Bioessay.: N. Rev. Mol., Cell. Dev. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib96","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/s41580-018-0001-6","article-title":"The coming of age of chaperone-mediated autophagy","volume":"19","author":"Kaushik","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib97","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cardiores.2005.08.014","article-title":"Autophagy in cardiac myocyte homeostasis, aging, and pathology","volume":"68","author":"Terman","year":"2005","journal-title":"Cardiovasc. Res."},{"issue":"25","key":"10.1016\/j.phrs.2022.106352_bib98","doi-asserted-by":"crossref","first-page":"21993","DOI":"10.1074\/jbc.M111.225805","article-title":"Caloric restriction mimetic 2-deoxyglucose antagonizes doxorubicin-induced cardiomyocyte death by multiple mechanisms","volume":"286","author":"Chen","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib99","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00441-012-1475-8","article-title":"Effects of doxorubicin cancer therapy on autophagy and the ubiquitin-proteasome system in long-term cultured adult rat cardiomyocytes","volume":"350","author":"Dimitrakis","year":"2012","journal-title":"Cell Tissue Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib100","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijcard.2008.01.043","article-title":"Adriamycin-induced autophagic cardiomyocyte death plays a pathogenic role in a rat model of heart failure","volume":"134","author":"Lu","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib101","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bcp.2014.01.040","article-title":"Ghrelin inhibits doxorubicin cardiotoxicity by inhibiting excessive autophagy through AMPK and p38-MAPK","volume":"88","author":"Wang","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib102","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/cvr\/cvs282","article-title":"Prior starvation mitigates acute doxorubicin cardiotoxicity through restoration of autophagy in affected cardiomyocytes","volume":"96","author":"Kawaguchi","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib103","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.bcp.2012.10.005","article-title":"Autophagy upregulation promotes survival and attenuates doxorubicin-induced cardiotoxicity","volume":"85","author":"Sishi","year":"2013","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib104","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1074\/jbc.M109.070037","article-title":"Transcription factor GATA4 inhibits doxorubicin-induced autophagy and cardiomyocyte death","volume":"285","author":"Kobayashi","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib105","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1124\/jpet.111.189589","article-title":"Resveratrol attenuates doxorubicin-induced cardiomyocyte death via inhibition of p70 S6 kinase 1-mediated autophagy","volume":"341","author":"Xu","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.phrs.2022.106352_bib106","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1016\/j.cellsig.2014.08.019","article-title":"The role of PI3K\/AKT\/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration","volume":"26","author":"Heras-Sandoval","year":"2014","journal-title":"Cell. Signal."},{"issue":"10","key":"10.1016\/j.phrs.2022.106352_bib107","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22101589","article-title":"Aspalathin reverts doxorubicin-induced cardiotoxicity through increased autophagy and decreased expression of p53\/mTOR\/p62 signaling","volume":"22","author":"Johnson","year":"2017","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib108","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.immuni.2007.05.022","article-title":"Toll-like receptor 4 is a sensor for autophagy associated with innate immunity","volume":"27","author":"Xu","year":"2007","journal-title":"Immunity"},{"issue":"7173","key":"10.1016\/j.phrs.2022.106352_bib109","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/nature06421","article-title":"Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis","volume":"450","author":"Sanjuan","year":"2007","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.phrs.2022.106352_bib110","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/ars.2020.8016","article-title":"Cardiac damage in anthracyclines therapy: focus on oxidative stress and inflammation","volume":"32","author":"Rocca","year":"2020","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.phrs.2022.106352_bib111","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.01.007","article-title":"Autophagic dysregulation in doxorubicin cardiomyopathy","volume":"104","author":"Bartlett","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib112","first-page":"1365","article-title":"[Protective effect of ginsenoside Rb\u2081 on doxorubicin-induced myocardial autophagy]","volume":"42","author":"Li","year":"2017","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"5","key":"10.1016\/j.phrs.2022.106352_bib113","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib114","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib115","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cell.2017.09.021","article-title":"Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease","volume":"171","author":"Stockwell","year":"2017","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.phrs.2022.106352_bib116","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat. Cell Biol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106352_bib117","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132747","article-title":"Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity","volume":"5","author":"Tadokoro","year":"2020","journal-title":"JCI Insight"},{"issue":"24","key":"10.1016\/j.phrs.2022.106352_bib118","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2015.61.7928","article-title":"Dexrazoxane in children with cancer: from evidence to practice","volume":"33","author":"Kremer","year":"2015","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00432-003-0498-7","article-title":"The current and future role of dexrazoxane as a cardioprotectant in anthracycline treatment: expert panel review","volume":"130","author":"Swain","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"23","key":"10.1016\/j.phrs.2022.106352_bib120","first-page":"8422","article-title":"Doxorubicin irreversibly inactivates iron regulatory proteins 1 and 2 in cardiomyocytes: evidence for distinct metabolic pathways and implications for iron-mediated cardiotoxicity of antitumor therapy","volume":"61","author":"Minotti","year":"2001","journal-title":"Cancer Res."},{"issue":"19","key":"10.1016\/j.phrs.2022.106352_bib121","doi-asserted-by":"crossref","first-page":"17179","DOI":"10.1074\/jbc.M111604200","article-title":"Transferrin receptor-dependent iron uptake is responsible for doxorubicin-mediated apoptosis in endothelial cells: role of oxidant-induced iron signaling in apoptosis","volume":"277","author":"Kotamraju","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib122","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1172\/JCI72931","article-title":"Cardiotoxicity of doxorubicin is mediated through mitochondrial iron accumulation","volume":"124","author":"Ichikawa","year":"2014","journal-title":"J. Clin. Investig."},{"issue":"8","key":"10.1016\/j.phrs.2022.106352_bib123","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1007\/s00109-014-1147-0","article-title":"Mice lacking mitochondrial ferritin are more sensitive to doxorubicin-mediated cardiotoxicity","volume":"92","author":"Maccarinelli","year":"2014","journal-title":"J. Mol. Med."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib124","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/s41419-021-03614-x","article-title":"Regulated cell death pathways in doxorubicin-induced cardiotoxicity","volume":"12","author":"Christidi","year":"2021","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib125","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1007\/s11010-021-04112-6","article-title":"Astragaloside IV inhibits adriamycin-induced cardiac ferroptosis by enhancing Nrf2 signaling","volume":"476","author":"Luo","year":"2021","journal-title":"Mol. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib126","first-page":"265","article-title":"Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs","volume":"11","author":"Krishna","year":"2000","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib127","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/07388551.2015.1015957","article-title":"Molecular mechanisms of drug resistance and its reversal in cancer","volume":"36","author":"Kartal-Yandim","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.phrs.2022.106352_bib128","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.bi.58.070189.001033","article-title":"The biochemistry of P-glycoprotein-mediated multidrug resistance","volume":"58","author":"Endicott","year":"1989","journal-title":"Annu. Rev. Biochem."},{"issue":"1\u20132","key":"10.1016\/j.phrs.2022.106352_bib129","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drup.2012.01.005","article-title":"Tyrosine kinase inhibitors as modulators of ABC transporter-mediated drug resistance","volume":"15","author":"Shukla","year":"2012","journal-title":"Drug Resist. Update.: Rev. Comment. Antimicrob. Anticancer Chemother."},{"key":"10.1016\/j.phrs.2022.106352_bib130","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-pharmtox-010715-103111","article-title":"Toward a better understanding of the complexity of cancer drug resistance","volume":"56","author":"Gottesman","year":"2016","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"issue":"12","key":"10.1016\/j.phrs.2022.106352_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10120503","article-title":"Transporter and lysosomal mediated (multi)drug resistance to tyrosine kinase inhibitors and potential strategies to overcome resistance","volume":"10","author":"de Klerk","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.phrs.2022.106352_bib132","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/978-981-13-7647-4_12","article-title":"A.B.C. transporter-mediated multidrug-resistant cancer","volume":"1141","author":"Amawi","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib133","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1093\/jnci\/81.2.116","article-title":"Expression of a multidrug resistance gene in human cancers","volume":"81","author":"Goldstein","year":"1989","journal-title":"J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib134","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1349-7006.2008.00744.x","article-title":"Influence of ABCB1 and ABCG2 polymorphisms on doxorubicin disposition in Asian breast cancer patients","volume":"99","author":"Lal","year":"2008","journal-title":"Cancer Sci."},{"issue":"35","key":"10.1016\/j.phrs.2022.106352_bib135","doi-asserted-by":"crossref","first-page":"56371","DOI":"10.18632\/oncotarget.10890","article-title":"Combining GRP78 suppression and MK2206-induced Akt inhibition decreases doxorubicin-induced P-glycoprotein expression and mitigates chemoresistance in human osteosarcoma","volume":"7","author":"Xia","year":"2016","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib136","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1002\/jcb.25890","article-title":"Oxidative stress promotes doxorubicin-induced Pgp and BCRP expression in colon cancer cells under hypoxic conditions","volume":"118","author":"Pinz\u00f3n-Daza","year":"2017","journal-title":"J. Cell. Biochem."},{"issue":"5","key":"10.1016\/j.phrs.2022.106352_bib137","doi-asserted-by":"crossref","first-page":"482","DOI":"10.4062\/biomolther.2016.145","article-title":"Involvement of NRF2 signaling in doxorubicin resistance of cancer stem cell-enriched colonospheres","volume":"24","author":"Ryoo","year":"2016","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.phrs.2022.106352_bib138","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.562376","article-title":"Quality control of radix astragali (The Root of Astragalus membranaceus var. mongholicus) along its value chains","volume":"11","author":"Bi","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib139","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/med.21785","article-title":"Phytochemistry and cardiovascular protective effects of Huang-Qi (Astragali Radix)","volume":"41","author":"Su","year":"2021","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2022.106352_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112895","article-title":"Astragali radix (Huangqi): a promising edible immunomodulatory herbal medicine","volume":"258","author":"Chen","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"9","key":"10.1016\/j.phrs.2022.106352_bib141","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/ptr.5188","article-title":"Review of the botanical characteristics, phytochemistry, and pharmacology of Astragalus membranaceus (Huangqi)","volume":"28","author":"Fu","year":"2014","journal-title":"Phytother. Res.: PTR"},{"key":"10.1016\/j.phrs.2022.106352_bib142","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.2147\/DDDT.S272355","article-title":"Astragaloside IV: an effective drug for the treatment of cardiovascular diseases","volume":"14","author":"Tan","year":"2020","journal-title":"Drug Des., Dev. Ther."},{"key":"10.1016\/j.phrs.2022.106352_bib143","article-title":"Astragaloside IV ameliorates myocardial infarction induced apoptosis and restores cardiac function","volume":"9","author":"Sun","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"5","key":"10.1016\/j.phrs.2022.106352_bib144","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.3892\/etm.2021.10631","article-title":"Astragaloside IV prevents endothelial dysfunction by improving oxidative stress in streptozotocin-induced diabetic mouse aortas","volume":"22","author":"Zhang","year":"2021","journal-title":"Exp. Ther. Med."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib145","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.freeradbiomed.2009.11.023","article-title":"Arjunolic acid, a triterpenoid saponin, prevents acetaminophen (APAP)-induced liver and hepatocyte injury via the inhibition of APAP bioactivation and JNK-mediated mitochondrial protection","volume":"48","author":"Ghosh","year":"2010","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib146","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.cbi.2007.08.001","article-title":"Arjunolic acid, a triterpenoid saponin, ameliorates arsenic-induced cyto-toxicity in hepatocytes","volume":"170","author":"Manna","year":"2007","journal-title":"Chem. -Biol. Interact."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib147","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00204-007-0272-8","article-title":"Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid","volume":"82","author":"Manna","year":"2008","journal-title":"Arch. Toxicol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib148","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22714","article-title":"Hepatoprotective effect of arjunolic acid against cisplatin-induced hepatotoxicity: targeting oxidative stress, inflammation, and apoptosis","volume":"35","author":"Sherif","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.phrs.2022.106352_bib149","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cyto.2015.10.010","article-title":"Renal protective effects of arjunolic acid in a cisplatin-induced nephrotoxicity model","volume":"77","author":"Elsherbiny","year":"2016","journal-title":"Cytokine"},{"issue":"21","key":"10.1016\/j.phrs.2022.106352_bib150","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1016\/j.biomaterials.2011.03.048","article-title":"The protective role of arjunolic acid against doxorubicin induced intracellular ROS dependent JNK-p38 and p53-mediated cardiac apoptosis","volume":"32","author":"Ghosh","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.phrs.2022.106352_bib151","doi-asserted-by":"crossref","first-page":"23","DOI":"10.5582\/ddt.2015.01004","article-title":"Chemical constituents and bioactivities of Panax ginseng (C. A. Mey.)","volume":"91","author":"Ru","year":"2015","journal-title":"Drug Discov. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib152","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1039\/C4NP00080C","article-title":"Recent advances in ginseng as cancer therapeutics: a functional and mechanistic overview","volume":"32","author":"Wong","year":"2015","journal-title":"Nat. Prod. Rep."},{"issue":"25","key":"10.1016\/j.phrs.2022.106352_bib153","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.2174\/1568026619666191018100848","article-title":"Recent advances in ginsenosides as potential therapeutics against breast cancer","volume":"19","author":"Guo","year":"2019","journal-title":"Curr. Top. Med Chem."},{"issue":"8","key":"10.1016\/j.phrs.2022.106352_bib154","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s12272-020-01265-8","article-title":"Therapeutic effects of ginsenosides on breast cancer growth and metastasis","volume":"43","author":"Jin","year":"2020","journal-title":"Arch. Pharm. Res"},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib155","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1186\/s12885-018-4299-4","article-title":"Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2","volume":"18","author":"Li","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.phrs.2022.106352_bib156","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112627","article-title":"Anticancer property of ginsenoside Rh2 from ginseng","volume":"203","author":"Li","year":"2020","journal-title":"Eur. J. Med Chem."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib157","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jgr.2017.10.004","article-title":"Pharmacological and medical applications of and ginsenosides: a review for use in cardiovascular diseases","volume":"42","author":"Kim","year":"2018","journal-title":"J. Ginseng Res."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib158","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0047-6374(95)01618-A","article-title":"Stimulatory effect of saponin from Panax ginseng on immune function of lymphocytes in the elderly","volume":"83","author":"Liu","year":"1995","journal-title":"Mech. Ageing Dev."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib159","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1254\/jphs.93.458","article-title":"Anti-stress effects of Ginkgo biloba and Panax ginseng: a comparative study","volume":"93","author":"Rai","year":"2003","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2022.106352_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104409","article-title":"Natural medicines for the treatment of fatigue: Bioactive components, pharmacology, and mechanisms","volume":"148","author":"Luo","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"29","key":"10.1016\/j.phrs.2022.106352_bib161","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.2217\/nnm-2021-0329","article-title":"Doxorubicin nanomedicine based on ginsenoside Rg1 with alleviated cardiotoxicity and enhanced antitumor activity","volume":"16","author":"Li","year":"2021","journal-title":"Nanomed. (Lond., Engl. )"},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib162","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1080\/10717544.2017.1391893","article-title":"Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy","volume":"24","author":"Li","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.phrs.2022.106352_bib163","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/506214","article-title":"Cardioprotective Effects of 20(S)-Ginsenoside Rh2 against Doxorubicin-Induced Cardiotoxicity In Vitro and In Vivo","volume":"2012","author":"Wang","year":"2012","journal-title":"Evid. -Based Complement. Altern. Med. eCAM"},{"issue":"23","key":"10.1016\/j.phrs.2022.106352_bib164","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1002\/rcm.3801","article-title":"Silver complexation and tandem mass spectrometry for differentiation of triterpenoid saponins from the roots of Pulsatilla chinensis (Bunge) Regel","volume":"22","author":"Cheng","year":"2008","journal-title":"Rapid Commun. Mass Spectrom.: RCM"},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib165","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/med.21353","article-title":"Betulinic acid and its derivatives as potential antitumor agents","volume":"35","author":"Zhang","year":"2015","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.phrs.2022.106352_bib166","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.biopha.2015.04.017","article-title":"Self-assembled betulinic acid protects doxorubicin induced apoptosis followed by reduction of ROS-TNF-\u03b1-caspase-3 activity","volume":"72","author":"Dash","year":"2015","journal-title":"Biomed. Pharmacother. = Biomedecine Pharmacother."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib167","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jep.2010.02.004","article-title":"23-Hydroxybetulinic acid from Pulsatilla chinensis (Bunge) Regel synergizes the antitumor activities of doxorubicin in vitro and in vivo","volume":"128","author":"Zheng","year":"2010","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib168","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3892\/mmr.2013.1791","article-title":"Protective effect of ocotillol against doxorubicin\u2011induced acute and chronic cardiac injury","volume":"9","author":"Fu","year":"2014","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.phrs.2022.106352_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114813","article-title":"Pristimerin suppresses colorectal cancer through inhibiting inflammatory responses and Wnt\/\u03b2-catenin signaling","volume":"386","author":"Zhao","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106352_bib170","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3389\/fphar.2019.00746","article-title":"Anti-cancer effects of pristimerin and the mechanisms: a critical review","volume":"10","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib171","first-page":"258","article-title":"Panax notoginseng saponins prevent colitis-associated colorectal cancer via inhibition IDO1 mediated immune regulation","volume":"20","author":"Li","year":"2022","journal-title":"Chin. J. Nat. Med."},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib172","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/ptr.5066","article-title":"Panax notoginseng attenuates experimental colitis in the azoxymethane\/dextran sulfate sodium mouse model","volume":"28","author":"Wen","year":"2014","journal-title":"Phytother. Res.: PTR"},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib173","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1124\/jpet.114.218750","article-title":"Notoginsenoside R1 attenuates experimental inflammatory bowel disease via pregnane X receptor activation","volume":"352","author":"Zhang","year":"2015","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib174","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ptr.5961","article-title":"Panax notoginseng saponins attenuate cardiomyocyte apoptosis through mitochondrial pathway in natural aging rats","volume":"32","author":"Zhou","year":"2018","journal-title":"Phytother. Res.: PTR"},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-2008-1034303","article-title":"Protective effect of saponins from Panax notoginseng against doxorubicin-induced cardiotoxicity in mice","volume":"74","author":"Liu","year":"2008","journal-title":"Planta Med."},{"issue":"12","key":"10.1016\/j.phrs.2022.106352_bib176","doi-asserted-by":"crossref","first-page":"5831","DOI":"10.7150\/thno.55574","article-title":"Saikosaponin D exhibits anti-leukemic activity by targeting FTO\/mA signaling","volume":"11","author":"Sun","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.phrs.2022.106352_bib177","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2019.106181","article-title":"Saikosaponin-d attenuated lipopolysaccharide-induced depressive-like behaviors via inhibiting microglia activation and neuroinflammation","volume":"80","author":"Su","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2022.106352_bib178","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41392-019-0037-x","article-title":"Saikosaponin D suppresses enterovirus A71 infection by inhibiting autophagy","volume":"4","author":"Li","year":"2019","journal-title":"Signal Transduct. Target. Ther."},{"issue":"21","key":"10.1016\/j.phrs.2022.106352_bib179","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222111383","article-title":"The ameliorative effects of saikosaponin in thioacetamide-induced liver injury and non-alcoholic fatty liver disease in mice","volume":"22","author":"Chang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.phrs.2022.106352_bib180","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1021\/acs.molpharmaceut.7b00469","article-title":"Pharmacokinetics and pharmacodynamics of the triterpenoid ursolic acid in regulating the antioxidant, anti-inflammatory, and epigenetic gene responses in rat leukocytes","volume":"14","author":"Zhang","year":"2017","journal-title":"Mol. Pharm."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib181","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0378-8741(95)90032-2","article-title":"Pharmacology of oleanolic acid and ursolic acid","volume":"49","author":"Liu","year":"1995","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2022.106352_bib182","doi-asserted-by":"crossref","first-page":"7022","DOI":"10.1039\/C9FO00749K","article-title":"Effects of diosgenin and its derivatives on atherosclerosis","volume":"10","author":"Wu","year":"2019","journal-title":"Food Funct."},{"key":"10.1016\/j.phrs.2022.106352_bib183","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.lfs.2018.08.039","article-title":"Dioscin ameliorates cardiac hypertrophy through inhibition of the MAPK and Akt\/GSK3\u03b2\/mTOR pathways","volume":"209","author":"Chen","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2022.106352_bib184","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.intimp.2017.06.008","article-title":"Diosgenin glucoside provides neuroprotection by regulating microglial M1 polarization","volume":"50","author":"Wang","year":"2017","journal-title":"Int. Immunopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib185","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3233\/JAD-180330","article-title":"Diosgenin attenuates lipopolysaccharide-induced Parkinson\u2019s disease by inhibiting the TLR\/NF-\u03baB pathway","volume":"64","author":"Li","year":"2018","journal-title":"J. Alzheimer\u2019S. Dis.: JAD"},{"key":"10.1016\/j.phrs.2022.106352_bib186","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.172942","article-title":"Apoptotic, necrotic, and antiproliferative activity of diosgenin and diosgenin glycosides on cervical cancer cells","volume":"871","author":"Hern\u00e1ndez-V\u00e1zquez","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106352_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174274","article-title":"Diosgenin attenuates tumor growth and metastasis in transgenic prostate cancer mouse model by negatively regulating both NF-\u03baB\/STAT3 signaling cascades","volume":"906","author":"Sikka","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2022.106352_bib188","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.intimp.2019.01.047","article-title":"Diosgenin ameliorates testicular damage in streptozotocin-diabetic rats through attenuation of apoptosis, oxidative stress, and inflammation","volume":"70","author":"Khosravi","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2022.106352_bib189","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114018","article-title":"Dioscin and diosgenin: insights into their potential protective effects in cardiac diseases","volume":"274","author":"Li","year":"2021","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2022.106352_bib190","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.redox.2018.02.026","article-title":"Protective effect of dioscin against doxorubicin-induced cardiotoxicity via adjusting microRNA-140-5p-mediated myocardial oxidative stress","volume":"16","author":"Zhao","year":"2018","journal-title":"Redox Biol."},{"key":"10.1016\/j.phrs.2022.106352_bib191","unstructured":"Diao Xin Xue Kang Jiaonang, Chinese Pharmacopoeia Commission, Chinese Pharmacopoeia (2020) 820\u2013821. https:\/\/www.scopus.com\/inward\/record.uri?eid=2-s2.0\u201385122281872&partnerID=40&md5=ab823c7ce4fe6d957e7d7dfd40c1dc1c."},{"key":"10.1016\/j.phrs.2022.106352_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114943","article-title":"Protective effect of Di\u2019ao Xinxuekang capsule against doxorubicin-induced chronic cardiotoxicity","volume":"287","author":"Li","year":"2022","journal-title":"J. Ethnopharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib193","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1248\/bpb.29.1267","article-title":"Antithrombotic activities of aqueous extract from Radix Ophiopogon japonicus and its two constituents","volume":"29","author":"Kou","year":"2006","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.phrs.2022.106352_bib194","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jep.2016.01.037","article-title":"Ophiopogon japonicus - a phytochemical, ethnomedicinal and pharmacological review","volume":"181","author":"Chen","year":"2016","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib195","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.neulet.2004.03.036","article-title":"Astragaloside IV protects against ischemic brain injury in a murine model of transient focal ischemia","volume":"363","author":"Luo","year":"2004","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.phrs.2022.106352_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104563","article-title":"Antiviral activity of astragaloside II, astragaloside III and astragaloside IV compounds against dengue virus: computational docking and in vitro studies","volume":"152","author":"Indu","year":"2021","journal-title":"Microb. Pathog."},{"issue":"12","key":"10.1016\/j.phrs.2022.106352_bib197","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1111\/j.2042-7158.2012.01549.x","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II","volume":"64","author":"Huang","year":"2012","journal-title":"J. Pharm. Pharmacol."},{"issue":"6","key":"10.1016\/j.phrs.2022.106352_bib198","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/jphp.12706","article-title":"Astragaloside II sensitizes human hepatocellular carcinoma cells to 5-fluorouracil via suppression of autophagy","volume":"69","author":"Wang","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib199","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/s-2003-38483","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng","volume":"69","author":"Choi","year":"2003","journal-title":"Planta Med."},{"issue":"5","key":"10.1016\/j.phrs.2022.106352_bib200","first-page":"4444","article-title":"Induction of apoptosis and reversal of permeability glycoprotein-mediated multidrug resistance of MCF-7\/ADM by ginsenoside Rh2","volume":"8","author":"Zhang","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.phrs.2022.106352_bib201","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2020.101452","article-title":"Ginsenoside Rh2 pretreatment and withdrawal reactivated the pentose phosphate pathway to ameliorate intracellular redox disturbance and promoted intratumoral penetration of adriamycin","volume":"32","author":"Liu","year":"2020","journal-title":"Redox Biol."},{"issue":"1","key":"10.1016\/j.phrs.2022.106352_bib202","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1476-5381.2011.01505.x","article-title":"Cellular pharmacokinetic mechanisms of adriamycin resistance and its modulation by 20(S)-ginsenoside Rh2 in MCF-7\/Adr cells","volume":"165","author":"Zhang","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.phrs.2022.106352_bib203","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1124\/dmd.112.045187","article-title":"Key role of nuclear factor-\u03baB in the cellular pharmacokinetics of adriamycin in MCF-7\/Adr cells: the potential mechanism for synergy with 20(S)-ginsenoside Rh2","volume":"40","author":"Zhang","year":"2012","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"issue":"8","key":"10.1016\/j.phrs.2022.106352_bib204","doi-asserted-by":"crossref","first-page":"8832","DOI":"10.3390\/molecules17088832","article-title":"Synthesis and biological activity of 23-hydroxybetulinic acid C-28 ester derivatives as antitumor agent candidates","volume":"17","author":"Bi","year":"2012","journal-title":"Molecules"},{"key":"10.1016\/j.phrs.2022.106352_bib205","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejmech.2014.09.058","article-title":"Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives","volume":"87","author":"Zhang","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.phrs.2022.106352_bib206","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.796745","article-title":"Involvement of P-gp on reversing multidrug resistance effects of 23-hydroxybetulinic acid on chemotherapeutic agents","volume":"12","author":"Liu","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2022.106352_bib207","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.prp.2017.01.022","article-title":"Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7\/adriamycin cells","volume":"213","author":"Li","year":"2017","journal-title":"Pathol., Res. Pract."},{"issue":"19","key":"10.1016\/j.phrs.2022.106352_bib208","first-page":"4437","article-title":"The effect of saikosaponin D on doxorubicin pharmacokinetics and its MDR reversal in MCF-7\/adr cell xenografts","volume":"21","author":"Li","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2022.106352_bib209","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jpba.2018.11.057","article-title":"Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin","volume":"165","author":"Zong","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"4","key":"10.1016\/j.phrs.2022.106352_bib210","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27041282","article-title":"Inhibitory effect of ursolic acid on the migration and invasion of doxorubicin-resistant breast cancer","volume":"27","author":"Zong","year":"2022","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib211","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/tox.23032","article-title":"Ursolic acid reduces Adriamycin resistance of human ovarian cancer cells through promoting the HuR translocation from cytoplasm to nucleus","volume":"36","author":"Li","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.phrs.2022.106352_bib212","doi-asserted-by":"crossref","first-page":"28403","DOI":"10.1038\/srep28403","article-title":"Dioscin strengthens the efficiency of adriamycin in MCF-7 and MCF-7\/ADR cells through autophagy induction: more than just down-regulation of MDR1","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2022.106352_bib213","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1021\/np400071c","article-title":"Dioscin restores the activity of the anticancer agent adriamycin in multidrug-resistant human leukemia K562\/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-\u03baB signaling inhibition","volume":"76","author":"Wang","year":"2013","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.phrs.2022.106352_bib214","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112304","article-title":"Paris saponin VII extracted from Trillium tschonoskii induces autophagy and apoptosis in NSCLC cells","volume":"248","author":"Qian","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"2","key":"10.1016\/j.phrs.2022.106352_bib215","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bcp.2014.01.018","article-title":"Paris saponin VII inhibits growth of colorectal cancer cells through Ras signaling pathway","volume":"88","author":"Li","year":"2014","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2022.106352_bib216","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.jep.2014.04.049","article-title":"Paris saponin VII from trillium tschonoskii reverses multidrug resistance of adriamycin-resistant MCF-7\/ADR cells via P-glycoprotein inhibition and apoptosis augmentation","volume":"154","author":"Li","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2022.106352_bib217","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jep.2018.12.018","article-title":"Paris saponin VII reverses chemoresistance in breast MCF-7\/ADR cells","volume":"232","author":"Li","year":"2019","journal-title":"J. Ethnopharmacol."},{"issue":"11","key":"10.1016\/j.phrs.2022.106352_bib218","first-page":"985","article-title":"Steroidal saponin of Trillium tschonoskii. Reverses multidrug resistance of hepatocellular carcinoma","volume":"20","author":"Wang","year":"2013","journal-title":"Phytomedicine Int. J. Phytother. Phytopharm."},{"key":"10.1016\/j.phrs.2022.106352_bib219","article-title":"Novel steroidal saponin isolated from Trillium tschonoskii maxim. exhibits anti-oxidative effect via autophagy induction in cellular and Caenorhabditis elegans models","volume":"65","author":"Wu","year":"2019","journal-title":"Phytomed. Int. J. Phytother. Phytopharm."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:43:35Z","timestamp":1760913815000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822002973"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":219,"alternative-id":["S1043661822002973"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106352","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Saponins and their derivatives: Potential candidates to alleviate anthracycline-induced cardiotoxicity and multidrug resistance","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106352","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106352"}}